Filing Details

Accession Number:
0001567619-19-004979
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-20 16:02:31
Reporting Period:
2019-02-15
Accepted Time:
2019-02-20 16:02:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Innoviva Inc. INVA Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1307047 Geoffrey Hulme 2000 Sierra Point Parkway
Suite 500
Brisbane CA 94005
Interim Peo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-15 7,000 $14.80 7,000 No 4 P Direct
Common Stock Acquisiton 2019-02-19 9,000 $0.00 16,000 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,500 Indirect See Footnote
Footnotes
  1. The reportable securities are owned directly by Steel Valley Capital LLC. The Reporting Person is the owner and manager of Steel Valley Capital LLC.